Free tool
FAERS Monitor: Norvir
Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations
Reports naming NDA 022417 or its brand name (Norvir, Ritonavir). Reports on generic versions are filed under their own applications.
Reports
29,122
Serious
26,508
91% of reports
Hospitalization
9,671
Death reported
2,649
Any cause; not necessarily from the drug
Most reported reactions
MedDRA preferred terms.
- drug interaction2,561
- foetal exposure during pregnancy2,398
- anxiety1,622
- pain1,573
- emotional distress1,388
- maternal exposure during pregnancy1,245
- anhedonia1,235
- nausea1,056
- diarrhoea1,021
- exposure during pregnancy1,015
- renal failure951
- fatigue906
- acute kidney injury904
- chronic kidney disease898
- depression869
Reports by year received
View as table
| Year | Reports |
|---|---|
| 2004 | 569 |
| 2005 | 619 |
| 2006 | 798 |
| 2007 | 909 |
| 2008 | 1,077 |
| 2009 | 1,368 |
| 2010 | 1,352 |
| 2011 | 1,246 |
| 2012 | 1,488 |
| 2013 | 1,465 |
| 2014 | 1,585 |
| 2015 | 2,154 |
| 2016 | 2,283 |
| 2017 | 1,802 |
| 2018 | 1,932 |
| 2019 | 1,715 |
| 2020 | 1,901 |
| 2021 | 1,434 |
| 2022 | 1,370 |
| 2023 | 913 |
| 2024 | 564 |
| 2025 | 384 |
| 2026 | 192 |
Disproportionality screen
Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 21,025,037 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.
| Reaction | Reports | PRR | 95% CI lower | Chi-squared |
|---|---|---|---|---|
| anhedoniaSignal | 1,235 | 35.6 | 33.6 | 39,553 |
| foetal exposure during pregnancySignal | 2,398 | 21.9 | 21.1 | 46,634 |
| exposure during pregnancySignal | 1,015 | 12.0 | 11.3 | 10,061 |
| drug interactionSignal | 2,561 | 11.8 | 11.4 | 25,170 |
| maternal exposure during pregnancySignal | 1,245 | 10.2 | 9.7 | 10,243 |
| chronic kidney diseaseSignal | 898 | 8.6 | 8.1 | 5,997 |
| emotional distressSignal | 1,388 | 8.4 | 7.9 | 8,941 |
| renal failureSignal | 951 | 5.2 | 4.9 | 3,221 |
| acute kidney injurySignal | 904 | 4.3 | 4.0 | 2,277 |
| anxietySignal | 1,622 | 4.1 | 3.9 | 3,881 |
| depressionSignal | 869 | 2.8 | 2.6 | 984 |
| pain | 1,573 | 1.9 | 1.8 | 632 |
| diarrhoea | 1,021 | 1.1 | 1.1 | 19 |
| nausea | 1,056 | 1.0 | 0.9 | 1 |
| fatigue | 906 | 0.8 | 0.8 | 28 |
A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.